Home NDC 0003-3624 REYATAZ
Product NDC 0003-3624
11-digit product format 000033624
Labeler code 0003
Product ID 0003-3624_1cab2232-648a-4961-a179-30087315de3b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ATAZANAVIR
Dosage form CAPSULE, GELATIN COATED
Route ORAL
Labeler E.R. Squibb & Sons, L.L.C.
Application NDA021567
Marketing category NDA
Marketing start 2003-06-24
Marketing end 2023-04-30
Substance ATAZANAVIR SULFATE
Active strength 150 mg/1
Pharmacologic classes Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0003-3624-12 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0003-3624-12 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0003-3624-12 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0003-3624-12 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0003-3624-12 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0003-3624-12 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0003-3624-12 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0003-3624-12 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0003-3624-12 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0003-3624-12 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0003-3624-12 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0003-3624-12 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021567-001 REYATAZ ATAZANAVIR SULFATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 N021567-002 REYATAZ ATAZANAVIR SULFATE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 N021567-003 REYATAZ ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 N021567-004 REYATAZ ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 94 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021567-001 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-002 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-003 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-004 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021567-001 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-002 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-003 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-004 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021567-001 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-002 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-003 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-004 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021567-001 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-002 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-003 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-004 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0003-3624-12 REYATAZ 60 in 1 BOTTLE, PLASTIC CAPSULE, GELATIN COATED 60 37
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ATAZANAVIR SULFATE ACTIVE INGREDIENT 4MT4VIE29P REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 ATAZANAVIR ACTIVE MOIETY QZU4H47A3S REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 ALCOHOL INACTIVE INGREDIENT 3K9958V90M REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 AMMONIA INACTIVE INGREDIENT 5138Q19F1X REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 GELATIN INACTIVE INGREDIENT 2G86QN327L REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 SHELLAC INACTIVE INGREDIENT 46N107B71O REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 SUCROSE INACTIVE INGREDIENT C151H8M554 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 22 ATAZANAVIR SULFATE ACTIVE INGREDIENT 4MT4VIE29P REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 ATAZANAVIR ACTIVE MOIETY QZU4H47A3S REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 ALCOHOL INACTIVE INGREDIENT 3K9958V90M REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 SHELLAC INACTIVE INGREDIENT 46N107B71O REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP REYATAZ (ATAZANAVIR SULFATE) CAPSULE, GELATIN COATED [PHYSICIANS TOTAL CARE, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0003-3624 REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] 36 Legacy NDC, 1 package rows 20241220_165cff62-b284-4a27-a65d-9ec8a5bfcdd8.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0003-3624-12 00003362412 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3624-12) 2003-06-24 2023-04-30 No No Current